An influenza A virus (H7N9) anti-neuraminidase monoclonal antibody with prophylactic and therapeutic activity in vivo

Zoonotic A(H7N9) avian influenza viruses emerged in China in 2013 and continue to be a threat to human public health, having infected over 800 individuals with a mortality rate approaching 40%. Treatment options for people infected with A(H7N9) include the use of neuraminidase (NA) inhibitors. Howev...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Antiviral Res
Main Authors: Wilson, Jason R., Guo, Zhu, Reber, Adrian, Kamal, Ram P., Music, Nedzad, Gansebom, Shane, Bai, Yaohui, Levine, Min, Carney, Paul, Tzeng, Wen-Pin, Stevens, James, York, Ian A.
Format: Artigo
Jezik:Inglês
Izdano: 2016
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5729279/
https://ncbi.nlm.nih.gov/pubmed/27713074
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.antiviral.2016.10.001
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki